← back to search

Yang Yu

Shandong University · CN
Area of research
Cancer Research · Surgery
Research interest
Research focused on Apoptosis and Downregulation and upregulation, with related work in Hepatocellular carcinoma, Cancer research, microRNA. Notable publications include 'Aloe-emodin attenuates myocardial infarction and apoptosis via up-regulating miR-133 expression', 'MicroRNA-98 negatively regulates myocardial infarction-induced apoptosis by down-regulating Fas and caspase-3', and 'Inhibition of MicroRNA-124 Reduces Cardiomyocyte Apoptosis Following Myocardial Infarction via Targeting STAT3'.
h-index
citations
228
works
13
NIH funding
primary concept
email

Recent publications

Clathrin Light Chain B Drives Hepatocellular Carcinoma Progression Through Dual Mechanisms: Small Extracellular Vesicle‐Mediated Angiogenesis and the NF‐κB–PCLAF Signaling Axis
Advanced Science 2025cited by 2position: lastdoi
ARF Biogel Enriched with Osteogenic Differentiation Regulators Guides BMSCs Osteogenic Differentiation toote Bone Tissue Regeneration after Osteonecrosis of the femoral head through Vascular Remodeling and Synchronized Regulation of Inflammatory Response
Research Square 2025cited by 1position: middledoi
ANGPTL4 Stabilizes Bone Morphogenetic Protein 7 Through Deubiquitination and Promotes HCC Proliferation via the SMAD/MAPK Pathway
DNA and Cell Biology 2024cited by 3position: lastdoi
RNA-seq shows Angiopoietin-like 4 promotes hepatocellular carcinoma progression by inducing M2 polarization of tumor-associated macrophages
International Journal of Biological Macromolecules 2024cited by 2position: lastdoi
Angiopoietin-Related Protein 4-Transcript 3 Increases the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma Cells and Inhibits Apoptosis
DNA and Cell Biology 2024cited by 1position: lastdoi
The Role of ANGPTL Gene Family Members in Hepatocellular Carcinoma
Disease Markers 2022cited by 12position: lastdoi
Long Noncoding RNA AC007639.1 Promotes the Pathogenesis and Progression of Hepatocellular Carcinoma Through Inhibiting Apoptosis and Stimulating Chemotherapeutic Resistance
Frontiers in Oncology 2021cited by 3position: lastdoi
Aloe-emodin attenuates myocardial infarction and apoptosis via up-regulating miR-133 expression
Pharmacological Research 2019cited by 68position: firstdoi
Inhibition of MicroRNA-124 Reduces Cardiomyocyte Apoptosis Following Myocardial Infarction via Targeting STAT3
Cellular Physiology and Biochemistry 2018cited by 42position: middledoi
MiR-216a exerts tumor-suppressing functions in renal cell carcinoma by targeting TLR4.
PubMed 2018cited by 24position: middle
MicroRNA-98 negatively regulates myocardial infarction-induced apoptosis by down-regulating Fas and caspase-3
Scientific Reports 2017cited by 65position: middledoi
Anti-apoptotic and apoptotic pathway analysis of arsenic trioxide-induced apoptosis in human gastric cancer SGC-7901 cells
Oncology Reports 2014cited by 5position: middledoi
Effects of Fas in combined treatment of TRAIL and arsenic trioxide-induced apoptosis in human gastric cancer cells
Carcinogenesis,Teratogenesis and Mutagenesis 2012cited by 0position: first

Grants

No grants ingested yet.

Frequent collaborators

Xiaoke Sun · Harbin Medical University6 papers (2021–2025)Guanghua Cui · Harbin Medical University6 papers (2021–2025)Yun Bai · Kunming University of Science and Technology6 papers (2021–2025)Zhimin Du · The First Affiliated Hospital, Sun Yat-sen University3 papers (2017–2019)Meiqi Wei · Harbin Medical University3 papers (2022–2024)Jing Guo · Kunming University of Science and Technology3 papers (2017–2019)Fang He · Harbin Medical University3 papers (2017–2019)Meijuan Ding · Harbin Medical University3 papers (2021–2025)Jialu Guo · Harbin Medical University3 papers (2024–2024)Yanying Liu · Guangxi University3 papers (2022–2024)Ning Zhao · National Patient Safety Foundation3 papers (2022–2025)Huibin Liu · Harbin Medical University3 papers (2017–2019)Juan Hu · Harbin Medical University2 papers (2018–2019)Xiuqing Yan · Harbin Medical University2 papers (2018–2019)Di Yang · Zunyi Medical University2 papers (2017–2018)Dan Lü · Nanjing Jiangning Hospital2 papers (2021–2022)Di Qu · Harbin Medical University2 papers (2022–2024)Jie Yu · Harbin Medical University2 papers (2018–2019)Junchen Guo · Harbin Medical University1 papers (2025–2025)Luyao Qin · Harbin Medical University1 papers (2024–2024)